Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. News
  7. Press Releases
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
Delayed Quote. Delayed London Stock Exchange - 07/26 11:35:23 am
174 GBX   -1.42%
12:01pTransaction in own shares
DJ
07/23Transaction in own shares
DJ
07/21Notice of Results
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ARIX BIOSCIENCE PLC
01/12ARIX BIOSCIENCE : Artios Pharma Expands US Leadership Team with the Appointment ..
PU
01/06ARIX BIOSCIENCE : Atox Bio Announces FDA Acceptance to File the NDA for Reltecim..
PU
2020ARIX BIOSCIENCE : Completion of sale of VelosBio
AQ
2020ARIX BIOSCIENCE : Atox Bio Announces FDA Acceptance to File the NDA for Reltecim..
PU
2020ARIX BIOSCIENCE : Artios and Merck KGaA announce global strategic collaboration
AQ
2020ARIX BIOSCIENCE : Aura Biosciences Announces AU-011 Data From Phase 1b/2 Clinica..
PU
2020HARPOON THERAPEUTICS : Reports Third Quarter 2020 Financial Results and Provides..
PU
2020ARIX BIOSCIENCE : VelosBio Announces First Patient Dosed in Phase 2 Trial of VLS..
PU
2020ARIX BIOSCIENCE : VelosBio Announces FDA Fast Track and Orphan Drug Designations..
PU
2020ARIX BIOSCIENCE PLC : - Notice of Results
PR
2020ARIX BIOSCIENCE PLC : - LogicBio announces IND clearance for LB-001
PR
2020PHARMAXIS : US$7 Million of US Bronchitol Launch Milestone Payment Brought Forwa..
PU
2020ARIX BIOSCIENCE PLC : - Amplyx announces positive Phase 2 data
PR
2020ARIX BIOSCIENCE : Atox Bio Announces a Positive Effect of Reltecimod on Resoluti..
PU
2020ARIX BIOSCIENCE PLC : - Atox Bio plans NDA submission for Q3 2020
PR
2020ARIX BIOSCIENCE PLC : - VelosBio completes $137 million Series B financing
PR
2020ARIX BIOSCIENCE PLC : - Director/PDMR Shareholding, Issue of Ordinary Shares
PR
2020ARIX BIOSCIENCE PLC : - Aura presents updated AU-011 clinical data at ARVO 2020
PR
2020ARIX BIOSCIENCE PLC : - Imara presents positive interim Phase 2a data at EHA
PR
2020ARIX BIOSCIENCE PLC : - Autolus AUTO1 and AUTO3 data at EHA
PR
2020ARIX BIOSCIENCE : to present at the Proactive One2One Biotech Forum
PU
2020ARIX BIOSCIENCE PLC : - Arix announces strategic and operational update
PR
2020ARIX BIOSCIENCE PLC : - Results of Annual General Meeting
PR
2020ARIX BIOSCIENCE : to Participate in Fireside Chat at the Jefferies Virtual Healt..
PU
2020ARIX BIOSCIENCE PLC : - Iterum announces topline Phase 3 data in complicated UTI
PR
2020ARIX BIOSCIENCE PLC : - Harpoon presents interim Phase 1 data for HPN424
PR
2020ARIX BIOSCIENCE PLC : - Autolus presents additional AUTO3 data in DLBCL
PR
2020ARIX BIOSCIENCE PLC : - Amplyx closes $53 million Series C extension
PR
2020ARIX BIOSCIENCE PLC : - Notice of Annual General Meeting
PR
2020PHARMAXIS : Chiesi Files Resubmission To Address FDA Bronchitol(Mannitol) Inhala..
PU
2020ARIX BIOSCIENCE : Pharmaxis Appoints Dr Neil Graham as Director
PU
2020ARIX BIOSCIENCE PLC : - Pharmaxis announces new data in myelofibrosis
PR
2020ARIX BIOSCIENCE PLC : - Harpoon doses first patient in multiple myeloma trial
PR
2020ARIX BIOSCIENCE PLC : - Director/PDMR Shareholding
PR
2020ARIX BIOSCIENCE PLC : - Autolus announces FDA acceptance of IND application
PR
2020ARIX BIOSCIENCE PLC : - Changes to Board of Directors and executive leadership
PR
2020ARIX BIOSCIENCE PLC : - Director/PDMR Shareholding
PR
2020ARIX BIOSCIENCE : Imara prices Nasdaq IPO
PU
2020ARIX BIOSCIENCE PLC : - Imara prices Nasdaq IPO
PR
2020Arix names Dr Roberto Iacone as Entrepreneur in Residence
AQ
2020ARIX BIOSCIENCE PLC : - Annual Results for the year ended 31 December 2019
PR
2020ARIX BIOSCIENCE : Dr Roberto Iacone appointed as EiR
PU
2020ARIX BIOSCIENCE PLC : - Dr Roberto Iacone appointed as EiR
PR
2020ARIX BIOSCIENCE : Update on Imara proposed initial public offering in the United..
AQ
2020ARIX BIOSCIENCE : Update on Imara proposed IPO in the United States
PU
2020ARIX BIOSCIENCE PLC : - Update on Imara proposed IPO in the United States
PR
2020ARIX BIOSCIENCE : Notice of Results
PU
2020ARIX BIOSCIENCE PLC : - Notice of Results
PR
2020ARIX BIOSCIENCE : Aura announces updated Phase 1b/2 clinical data
PU
2020ARIX BIOSCIENCE PLC : - Aura announces updated Phase 1b/2 clinical data
PR
2020ARIX BIOSCIENCE : Imara files for proposed IPO in the United States
PU
2020ARIX BIOSCIENCE PLC : - Imara files for proposed IPO in the United States
PR
2020ARIX BIOSCIENCE : Autolus presents encouraging additional AUTO3 data
PU
2020ARIX BIOSCIENCE PLC : - Autolus presents encouraging additional AUTO3 data
PR
2020ARIX BIOSCIENCE : co-founds Quench Bio with Series a financing
AQ
2020QUENCH BIO : Closes $50M Series A Financing to Advance First-in-Class Medicines ..
PR
2020ARIX BIOSCIENCE PLC : - Arix co-founds Quench Bio with Series A financing
PR
2020ARIX BIOSCIENCE PLC : - Autolus announces pricing of public offering
PR
2020ARIX BIOSCIENCE : Iterum announces $52 million private placement
AQ
2020ARIX BIOSCIENCE : Iterum announces $52 million private placement
PU
2020ARIX BIOSCIENCE PLC : - Iterum announces $52 million private placement
PR
2019ARIX BIOSCIENCE PLC : - Pharmaxis business update
PR
2019ARIX BIOSCIENCE PLC : - Board changes
PR
2019ARIX BIOSCIENCE PLC : - Iterum announces topline Phase 3 data
PR
2019ARIX BIOSCIENCE PLC : - Autolus announces new AUTO3 data at ASH
PR
2019ARIX BIOSCIENCE PLC : - Autolus announces key new data at ASH
PR
2019ARIX BIOSCIENCE : Autolus Therapeutics Announces New Data Showcasing Clinical Pr..
PU
2019ARIX BIOSCIENCE PLC : - Holding(s) in Company
PR
2019ARIX BIOSCIENCE : Harpoon Therapeutics and AbbVie Announce Licensing and Option ..
PU
2019ARIX BIOSCIENCE PLC : - Harpoon and AbbVie announce licensing and option deal
PR
2019ARIX BIOSCIENCE PLC : - Autolus reports Q3 2019 financial results
PR
2019ARIX BIOSCIENCE PLC : - Change of Broker
PR
2019ARIX BIOSCIENCE PLC : - Autolus to present new data at the ASH Annual Meeting
PR
2019ARIX BIOSCIENCE : Artios expands DNA damage response pipeline with new asset
PU
2019ARIX BIOSCIENCE PLC : - Artios expands DDR pipeline with new asset
PR
1  2  3  4Next
Upcoming event on ARIX BIOSCIENCE PLC